<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APLS) is a clinicolaboratory symptom complex characterized by development of venous and/or arterial thromboses, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, obstetric pathology arising in the presence of hyperproduction of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (APAB) </plain></SENT>
<SENT sid="1" pm="."><plain>APLS may occur not only in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) or other <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> as secondary APLS, but in those without the above diseases as the primary APLS </plain></SENT>
<SENT sid="2" pm="."><plain>The authors have examined 34 patients with APLS versus 10 patients with a verified SLE free of APLS manifestations </plain></SENT>
<SENT sid="3" pm="."><plain>Affection of the valves was found in 30 patients with APLS (88%) </plain></SENT>
<SENT sid="4" pm="."><plain>More frequent were additional structures on mitral and aortic valve cusps, thickening of mitral valve cusps in APLS patients </plain></SENT>
<SENT sid="5" pm="."><plain>Evident valvular disease was seen only in APLS patients with high positive levels of APAB </plain></SENT>
<SENT sid="6" pm="."><plain>Valvular lesions were similar in patients with primary and secondary APLS </plain></SENT>
<SENT sid="7" pm="."><plain>The study has revealed a relationship between the presence of antibodies to <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and <z:hpo ids='HP_0001654'>valvular abnormalities</z:hpo> in APLS patients </plain></SENT>
</text></document>